In the Darker Shadow of Science: The Subjugation of Cancer

This year, in the U.S. alone, about 570,000 people are expected to die of cancer. That’s more than 1,500 people a day. Billions of dollars are spent each year in cancer research, but we have yet to find a cure.

Dr. Robert Jones came upon a radical idea in 1974. He realized that disrupting energy metabolism within cancer cells might perhaps be the key to stopping the growth of malignant tumors and, therefore, stopping cancer in its tracks. The drug Promethazine not only stops tumor growth, but has little of the side effects of current treatments and is affordable. The problem is that the established oncologists, researchers, pharmaceutical companies, and charities refuse to listen to his findings. As the project continued, funding and professional contacts disappeared, even though Jones has been able to show proven evidence of its use and benefit in many patients.

In the Darker Shadow of Science is the story of Jones’s struggle to get his cancer cure out in front of the public. The lack of response he has received from the community that is supposed to be doing everything they can to fight this disease is frankly terrifying. For more than thirty years, he has been trying to get someone, anyone, to listen, and the doors are proverbially shut in his face again and again.

Jones thinks he knows why. In the most simplistic terms, the cancer community is invested in not finding a humane and affordable cure. Think about it, what would oncologists do if there was suddenly a cure? They would have no practice. What would drug companies tell their stockholders when they have spent billions on cancer research, when a drug like Promethazine can cure cancer for pennies on the dollar?

You can’t help but feel that the reason that Jones felt compelled to write this is to warn us and, ultimately, to save lives. It makes you wonder about just what your tax dollars and donations are actually funding. This is a message that we need to hear, that the cancer community needs to hear, as well.